SciELO - Scientific Electronic Library Online

 
vol.32 suppl.1Indications for hematopoietic stem cell transplantation in adults in acute lymphoblastic leukemiaBone marrow transplantation in myelodysplastic syndromes author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Hematologia e Hemoterapia

Print version ISSN 1516-8484

Abstract

SILLA, Lucia Mariano R. et al. Hematopoietic stem cells transplantation and acute myeloid leukemia: Brazilian guidelines. Rev. Bras. Hematol. Hemoter. [online]. 2010, vol.32, suppl.1, pp.61-65.  Epub Apr 23, 2010. ISSN 1516-8484.  https://doi.org/10.1590/S1516-84842010005000024.

The objective of this work was to define guidelines for the indication of hematopoietic stem cells transplantation (HSCT) in the treatment of acute myeloid leukemia (AML) in Brazil. The role of HSCT in the treatment of AML was discussed by the authors and presented to the Brazilian Society of Bone Marrow Transplantation in a meeting to formulate and ratify the Brazilian Guidelines on HSCT. This consensus was based on a review of international publications and on the Brazilian experience in HSCT for the treatment of AML. The optimal treatment for AML in first complete remission (1CR) has not been defined yet. There is consensus on the indication of allogeneic HSCT with myeloablative conditioning for patients who present high risk cytogenetic changes. Allogeneic HSCT is not indicated for low cytogenetic risk 1RC patients and, apparently, allogeneic and autologous HSCT and consolidation chemotherapy are similar for intermediate risk patients.

Keywords : Hematopoietic stem cell transplantation; bone marrow; acute myeloid leukemia.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License